Evidence map›Paper›PMID 38974519›Full record

ArticleFrontiers in physiology2024

Effects of regulator of G protein signaling 2 (RGS2) overexpression in the paraventricular nucleus on blood pressure in rats with angiotensin II-induced hypertension.

Shane H Boomer, Xuefei Liu, Hong Zheng

Abstract read
In one paragraph

Article in Frontiers in physiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shane H BoomerBasic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, SD, United States.
Xuefei LiuBasic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, SD, United States.
Hong ZhengBasic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, SD, United States.

Funding

Novel target mechanism (renal nerves) for the beneficial actions of SGLT2 inhibition in congestive heart failureR01DK129311 · NIDDK · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PATEL, KAUSHIK P, ZHENG, HONG · 2021 to 2024
$2.0M
G-RISE University of South DakotaT32GM136503 · NIGMS · UNIVERSITY OF SOUTH DAKOTA · PI BAUGH, LEE, BURRELL, BRIAN DONALD · 2020 to 2024
$1.1M
NIDDK NIH HHS R01 DK129311NIGMS NIH HHS T32 GM136503
6 · The paper itself

Abstract

The hypothalamic paraventricular nucleus (PVN) regulates sympathetic activity and blood pressure. The regulator of G protein signaling 2 (RGS2) is a negative G protein regulator, which selectively regulates G⍺q signaling, a potential cause of hypertension. This study aimed to examine angiotensin II (ANG II)-G protein-RGS2 signaling on the central mechanisms of blood pressure control, sympathetic activation, and kidney function. The Sprague Dawley rats were infused with ANG II (200 ng/kg/min) via osmotic mini pump to induce hypertension. Adenovirus (AV) vectors encoding RGS2 was transfected into the PVN

Indexed as

angiotensin-IIblood pressureG-protein-coupled receptorhypertensionparaventricular nucleusregulator of G-protein signaling 2

Identifiers

PMID38974519
PMCPMC11224644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.